Special articleA framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Under an Elsevier user license
open archive
Key words
precision medicine
targeted therapies
biomarkers
genomics
next-generation sequencing
classification system
Cited by (0)
Copyright © 2018 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.